Medical device labelers have been working hard to comply with the FDA's Final Rule for Unique Device Identification (UDI). But what happens to a UDI record after submission? Reserve Your Spot Today!

Quantitative systems pharmacology modeling (QSPM) approaches help answer complex, critical Go/No-go decisions in drug R&D. Learn how to leverage QSPM to shorten timelines, lower cost, and increase the likelihood of developing best-in-class drugs. Register Now!

According to recent reports from the Tufts Center for the Study of Drug Development (CSDD), only about 12% of drugs that begin clinical testing eventually gain regulatory approval, and those few successes require an average of 15 years of development. Download this eBook to learn how to address development challenges early on and improve a drug’s path to market.

Digital health is not only changing the way patient data is collected in healthcare, but it is also disrupting the way the pharmaceutical industry gathers data from clinical trial participants.Download this eBook to learn 4 key ways pharmaceutical companies can leverage patient-generated data to implement a digital health strategy.